Evolution Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Evolution Wealth Management's LLY Position: Q1 2026 in Review
Evolution Wealth Management increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $44.6K and bringing the position to 323 shares worth $297K. The position accounts for 0.22% of the portfolio, ranked #78.
Evolution Wealth Management first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $300K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Evolution Wealth Management held 323 shares of Eli Lilly worth $297K as of Q1 2026.
- Evolution Wealth Management bought 44 Eli Lilly shares in Q1 2026, an estimated $44.6K.
- Eli Lilly made up 0.22% of Evolution Wealth Management's portfolio in Q1 2026, its #78 holding.
- Evolution Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
- Evolution Wealth Management's Eli Lilly position peaked at $300K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Evolution Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.